Advertisement

Topics

US court finds Supernus' Oxtellar XR patents valid and infringed by TWi Pharma

09:59 EDT 17 Aug 2017 | PharmaBiz

Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of CNS diseases, announced, following a four─day bench trial, that the

Original Article: US court finds Supernus' Oxtellar XR patents valid and infringed by TWi Pharma

NEXT ARTICLE

More From BioPortfolio on "US court finds Supernus' Oxtellar XR patents valid and infringed by TWi Pharma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...